Correlation Between Milestone Pharmaceuticals and Edgewise Therapeutics
Can any of the company-specific risk be diversified away by investing in both Milestone Pharmaceuticals and Edgewise Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Milestone Pharmaceuticals and Edgewise Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Milestone Pharmaceuticals and Edgewise Therapeutics, you can compare the effects of market volatilities on Milestone Pharmaceuticals and Edgewise Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Milestone Pharmaceuticals with a short position of Edgewise Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Milestone Pharmaceuticals and Edgewise Therapeutics.
Diversification Opportunities for Milestone Pharmaceuticals and Edgewise Therapeutics
0.39 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Milestone and Edgewise is 0.39. Overlapping area represents the amount of risk that can be diversified away by holding Milestone Pharmaceuticals and Edgewise Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Edgewise Therapeutics and Milestone Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Milestone Pharmaceuticals are associated (or correlated) with Edgewise Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Edgewise Therapeutics has no effect on the direction of Milestone Pharmaceuticals i.e., Milestone Pharmaceuticals and Edgewise Therapeutics go up and down completely randomly.
Pair Corralation between Milestone Pharmaceuticals and Edgewise Therapeutics
Given the investment horizon of 90 days Milestone Pharmaceuticals is expected to generate 1.75 times more return on investment than Edgewise Therapeutics. However, Milestone Pharmaceuticals is 1.75 times more volatile than Edgewise Therapeutics. It trades about 0.31 of its potential returns per unit of risk. Edgewise Therapeutics is currently generating about -0.11 per unit of risk. If you would invest 143.00 in Milestone Pharmaceuticals on August 30, 2024 and sell it today you would earn a total of 44.00 from holding Milestone Pharmaceuticals or generate 30.77% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Milestone Pharmaceuticals vs. Edgewise Therapeutics
Performance |
| Timeline |
| Milestone Pharmaceuticals |
| Edgewise Therapeutics |
Milestone Pharmaceuticals and Edgewise Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Milestone Pharmaceuticals and Edgewise Therapeutics
The main advantage of trading using opposite Milestone Pharmaceuticals and Edgewise Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Milestone Pharmaceuticals position performs unexpectedly, Edgewise Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Edgewise Therapeutics will offset losses from the drop in Edgewise Therapeutics' long position.The idea behind Milestone Pharmaceuticals and Edgewise Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Edgewise Therapeutics vs. Century Therapeutics | Edgewise Therapeutics vs. C4 Therapeutics | Edgewise Therapeutics vs. Mineralys Therapeutics, Common | Edgewise Therapeutics vs. Cullinan Oncology LLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |